Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer
Abstract Tetrathiomolybdate (TM) is a novel, copper-depleting compound associated with promising survival in a phase II study of patients with high-risk and triple-negative breast cancer. We sought to elucidate the mechanism of TM by exploring its effects on collagen processing and immune function i...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/37a653a1d4054f088c420dae713f918a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:37a653a1d4054f088c420dae713f918a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:37a653a1d4054f088c420dae713f918a2021-12-02T15:09:17ZTetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer10.1038/s41523-021-00313-w2374-4677https://doaj.org/article/37a653a1d4054f088c420dae713f918a2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41523-021-00313-whttps://doaj.org/toc/2374-4677Abstract Tetrathiomolybdate (TM) is a novel, copper-depleting compound associated with promising survival in a phase II study of patients with high-risk and triple-negative breast cancer. We sought to elucidate the mechanism of TM by exploring its effects on collagen processing and immune function in the tumor microenvironment (TME). Using an exploratory cohort, we identified markers of collagen processing (LOXL2, PRO-C3, C6M, and C1M) that differed between those with breast cancer versus controls. We measured these collagen biomarkers in TM-treated patients on the phase II study and detected evidence of decreased collagen cross-linking and increased degradation over formation in those without disease compared to those who experienced disease progression. Preclinical studies revealed decreased collagen deposition, lower levels of myeloid-derived suppressor cells, and higher CD4+ T-cell infiltration in TM-treated mice compared with controls. This study reveals novel mechanisms of TM targeting the TME and immune response with potential applications across cancer types.Ying L. LiuCecilie Liv BagerNicholas WillumsenDivya RamchandaniNaomi KornhauserLu LingMarta CobhamEleni AndreopoulouTessa CiglerAnne MooreDayle LaPollaVeronica FitzpatrickMaureen WardJ. David WarrenClaudia FischbachVivek MittalLinda T. VahdatNature PortfolioarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Breast Cancer, Vol 7, Iss 1, Pp 1-11 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 |
spellingShingle |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Ying L. Liu Cecilie Liv Bager Nicholas Willumsen Divya Ramchandani Naomi Kornhauser Lu Ling Marta Cobham Eleni Andreopoulou Tessa Cigler Anne Moore Dayle LaPolla Veronica Fitzpatrick Maureen Ward J. David Warren Claudia Fischbach Vivek Mittal Linda T. Vahdat Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer |
description |
Abstract Tetrathiomolybdate (TM) is a novel, copper-depleting compound associated with promising survival in a phase II study of patients with high-risk and triple-negative breast cancer. We sought to elucidate the mechanism of TM by exploring its effects on collagen processing and immune function in the tumor microenvironment (TME). Using an exploratory cohort, we identified markers of collagen processing (LOXL2, PRO-C3, C6M, and C1M) that differed between those with breast cancer versus controls. We measured these collagen biomarkers in TM-treated patients on the phase II study and detected evidence of decreased collagen cross-linking and increased degradation over formation in those without disease compared to those who experienced disease progression. Preclinical studies revealed decreased collagen deposition, lower levels of myeloid-derived suppressor cells, and higher CD4+ T-cell infiltration in TM-treated mice compared with controls. This study reveals novel mechanisms of TM targeting the TME and immune response with potential applications across cancer types. |
format |
article |
author |
Ying L. Liu Cecilie Liv Bager Nicholas Willumsen Divya Ramchandani Naomi Kornhauser Lu Ling Marta Cobham Eleni Andreopoulou Tessa Cigler Anne Moore Dayle LaPolla Veronica Fitzpatrick Maureen Ward J. David Warren Claudia Fischbach Vivek Mittal Linda T. Vahdat |
author_facet |
Ying L. Liu Cecilie Liv Bager Nicholas Willumsen Divya Ramchandani Naomi Kornhauser Lu Ling Marta Cobham Eleni Andreopoulou Tessa Cigler Anne Moore Dayle LaPolla Veronica Fitzpatrick Maureen Ward J. David Warren Claudia Fischbach Vivek Mittal Linda T. Vahdat |
author_sort |
Ying L. Liu |
title |
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer |
title_short |
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer |
title_full |
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer |
title_fullStr |
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer |
title_full_unstemmed |
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer |
title_sort |
tetrathiomolybdate (tm)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/37a653a1d4054f088c420dae713f918a |
work_keys_str_mv |
AT yinglliu tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT cecilielivbager tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT nicholaswillumsen tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT divyaramchandani tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT naomikornhauser tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT luling tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT martacobham tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT eleniandreopoulou tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT tessacigler tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT annemoore tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT daylelapolla tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT veronicafitzpatrick tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT maureenward tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT jdavidwarren tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT claudiafischbach tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT vivekmittal tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer AT lindatvahdat tetrathiomolybdatetmassociatedcopperdepletioninfluencescollagenremodelingandimmuneresponseinthepremetastaticnicheofbreastcancer |
_version_ |
1718387806320984064 |